Lianging Zheng

Outcomes of Patients Aged 65 Years in ZUMA-1, a Pivotal Phase 1/2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Refractory Large B Cell Lymphoma

Purpose of the Study: Axicel is an autologous anti-CD19 chimeric antigen receptor (CAR) T cell therapy approved by the US Food and Drug Administration for the treatment of patients with r...

Sattva S. Neelapu ;

Javier Munoz ;

Olalekan O. Oluwole ;

Caron A. Jacobson ;

Abhinav Deol ;

David B. Miklos ;

Nancy L. Bartlett , MD;

Ira Braunschweig ;

Yizhou Jiang ;

Jenny J. Kim ;

Lianging Zheng ;

John M. Rossi ;

Frederick L. Locke ;

10/22/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Lianging Zheng

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products